These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 39084295

  • 1. High glutamic acid decarboxylase antibody titers may be associated with a decline in β-cell function over time and future insulin deficiency in latent autoimmune diabetes in adults.
    Haisa A, Oikawa Y, Satomura A, Suzuki S, Nakanishi S, Fujisawa M, Morita H, Katsuki T, Shimada A.
    Diabetes Res Clin Pract; 2024 Sep; 215():111799. PubMed ID: 39084295
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Clinical and genetic characteristics of people with type 1 diabetes who have discrepancies in titers of anti-glutamic acid decarboxylase antibody measured by radioimmunoassay and enzyme-linked immunosorbent assay.
    Takagi S, Miura J, Hoshina S, Uchigata Y, Babazono T.
    J Diabetes Investig; 2020 Mar; 11(2):356-362. PubMed ID: 31267698
    [Abstract] [Full Text] [Related]

  • 4. GAD antibodies in T1D and LADA--relations to age, BMI, c-peptide, IA-2 and HLA-DRB1*03 and DRB1*04 alleles.
    Weber P, Ambrosova P, Canov P, Weberova D, Kuklinek P, Meluzinova H, Matejovska-Kubesova H, Cejkova P, Bielakova K, Cerna M.
    Adv Gerontol; 2011 Mar; 24(2):312-8. PubMed ID: 21957594
    [Abstract] [Full Text] [Related]

  • 5. Glutamic Acid Decarboxylase Autoantibody Detection by Electrochemiluminescence Assay Identifies Latent Autoimmune Diabetes in Adults with Poor Islet Function.
    Zhu Y, Qian L, Liu Q, Zou J, Zhou Y, Yang T, Huang G, Zhou Z, Liu Y.
    Diabetes Metab J; 2020 Apr; 44(2):260-266. PubMed ID: 31769235
    [Abstract] [Full Text] [Related]

  • 6. Decline Pattern of Beta-cell Function in Adult-onset Latent Autoimmune Diabetes: an 8-year Prospective Study.
    Li X, Chen Y, Xie Y, Xiang Y, Yan X, Huang G, Zhou Z.
    J Clin Endocrinol Metab; 2020 Jul 01; 105(7):. PubMed ID: 32307525
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Latent autoimmune diabetes in adults with low-titer GAD antibodies: similar disease progression with type 2 diabetes: a nationwide, multicenter prospective study (LADA China Study 3).
    Liu L, Li X, Xiang Y, Huang G, Lin J, Yang L, Zhao Y, Yang Z, Hou C, Li Y, Liu J, Zhu D, Leslie RD, Wang X, Zhou Z, LADA China Study Group.
    Diabetes Care; 2015 Jan 01; 38(1):16-21. PubMed ID: 25336751
    [Abstract] [Full Text] [Related]

  • 9. Glutamic acid decarboxylase 65 autoantibody levels discriminate two subtypes of latent autoimmune diabetes in adults.
    Li X, Yang L, Zhou Z, Huang G, Yan X.
    Chin Med J (Engl); 2003 Nov 01; 116(11):1728-32. PubMed ID: 14642146
    [Abstract] [Full Text] [Related]

  • 10. Frequency, immunogenetics, and clinical characteristics of latent autoimmune diabetes in China (LADA China study): a nationwide, multicenter, clinic-based cross-sectional study.
    Zhou Z, Xiang Y, Ji L, Jia W, Ning G, Huang G, Yang L, Lin J, Liu Z, Hagopian WA, Leslie RD, LADA China Study Group.
    Diabetes; 2013 Feb 01; 62(2):543-50. PubMed ID: 23086039
    [Abstract] [Full Text] [Related]

  • 11. The prevalence and characteristics of latent autoimmune diabetes in adults (LADA) and its relation with chronic complications in a clinical department of a university hospital in Korea.
    Roh MO, Jung CH, Kim BY, Mok JO, Kim CH.
    Acta Diabetol; 2013 Apr 01; 50(2):129-34. PubMed ID: 20953640
    [Abstract] [Full Text] [Related]

  • 12. GAD autoantibody affinity in adult patients with latent autoimmune diabetes, the study participants of a GAD65 vaccination trial.
    Krause S, Landherr U, Agardh CD, Hausmann S, Link K, Hansen JM, Lynch KF, Powell M, Furmaniak J, Rees-Smith B, Bonifacio E, Ziegler AG, Lernmark A, Achenbach P.
    Diabetes Care; 2014 Jun 01; 37(6):1675-80. PubMed ID: 24598244
    [Abstract] [Full Text] [Related]

  • 13. [Identification of the two subtypes of latent autoimmune diabetes in adults by glutamic acid decarboxylase 65 antibody titers].
    Li X, Zhou ZG, Huang G, Yan X, Yang L, Hu BY.
    Zhonghua Nei Ke Za Zhi; 2003 Jan 01; 42(1):7-10. PubMed ID: 12757655
    [Abstract] [Full Text] [Related]

  • 14. Number of autoantibodies and HLA genotype, more than high titers of glutamic acid decarboxylase autoantibodies, predict insulin dependence in latent autoimmune diabetes of adults.
    Maioli M, Pes GM, Delitala G, Puddu L, Falorni A, Tolu F, Lampis R, Orrù V, Secchi G, Cicalò AM, Floris R, Madau GF, Pilosu RM, Whalen M, Cucca F.
    Eur J Endocrinol; 2010 Oct 01; 163(4):541-9. PubMed ID: 20603341
    [Abstract] [Full Text] [Related]

  • 15. Subtle hyperproinsulinaemia characterises the defective insulin secretory capacity in offspring of glutamic acid decarboxylase antibody-positive patients with latent autoimmune diabetes mellitus in adults.
    Vauhkonen I, Niskanen L, Knip M, Mykkänen LM, Haffner S, Uusitupa M, Laakso M.
    Eur J Endocrinol; 2005 Aug 01; 153(2):265-73. PubMed ID: 16061833
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prediction of future insulin-deficiency in glutamic acid decarboxylase autoantibody enzyme-linked immunosorbent assay-positive patients with slowly-progressive type 1 diabetes.
    Kawasaki E, Awata T, Ikegami H, Imagawa A, Oikawa Y, Osawa H, Katsuki T, Kanatsuna N, Kawamura R, Kozawa J, Kodani N, Kobayashi T, Shimada A, Shimoda M, Takahashi K, Chujo D, Tsujimoto T, Tsuchiya K, Terakawa A, Terasaki J, Nagasawa K, Noso S, Fukui T, Horie I, Yasuda K, Yasuda H, Yanai H, Hanafusa T, Kajio H, Japanese Type 1 Diabetes Database Study (TIDE‐J).
    J Diabetes Investig; 2024 Jul 01; 15(7):835-842. PubMed ID: 38451108
    [Abstract] [Full Text] [Related]

  • 19. IgG4-subclass of glutamic acid decarboxylase antibody is more frequent in latent autoimmune diabetes in adults than in type 1 diabetes.
    Hillman M, Törn C, Thorgeirsson H, Landin-Olsson M.
    Diabetologia; 2004 Nov 01; 47(11):1984-9. PubMed ID: 15565370
    [Abstract] [Full Text] [Related]

  • 20. Clinical characteristics of anti-glutamic acid decarboxylase antibody-positive fulminant type 1 diabetes.
    Saito D, Oikawa Y, Mizutani G, Inoue K, Hatano M, Inoue I, Noda M, Shimada A.
    Endocr J; 2019 Apr 25; 66(4):329-336. PubMed ID: 30760658
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.